Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conivaptan for Cerebral Edema in ICH
NCT03000283Phase 1Completed
- Start
- Mar 2017
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of conivaptan in intracerebral hemorrhage (ICH) and cerebral edema. Primary endpoint: Patient Tolerance of Conivaptan. Started Mar 2017; status: completed.
02
Drugs
conivaptan
03
Conditions
intracerebral hemorrhage (ICH)cerebral edema
Beyond the preview
Go deeper on NCT03000283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03000283.